Related Experiment Video

Updated: Jun 7, 2026

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers
12:30

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers

Published on: August 12, 2014

An androgenic steroid delivery vector that imparts activity to a non-conventional platinum(II) metallo-drug

Martin Huxley1, Carlos Sanchez-Cano, Michael J Browning

  • 1Department of Chemistry, University of Warwick, Coventry, UK.

Dalton Transactions (Cambridge, England : 2003)
|October 30, 2010
PubMed

Insights

New platinum(II) complexes linked to androgens show enhanced tumor cell targeting. These androgenic platinum conjugates are more efficiently delivered into cells, creating potent drugs from inactive components.

Area of Science:

  • Medicinal Chemistry
  • Oncology
  • Nanotechnology

Background:

  • Many tumors exhibit elevated androgen receptor (AR) levels.
  • Targeting AR-positive tumors is a key strategy in cancer therapy.
  • Platinum(II) complexes are established chemotherapeutic agents.

Purpose of the Study:

  • To synthesize novel androgen conjugates with platinum(II) complexes.
  • To improve the targeted delivery of platinum(II) agents into tumor cells.
  • To investigate the synergistic effects of combining androgens and platinum(II) for enhanced anticancer activity.

Main Methods:

  • Synthesis of various androgen-platinum(II) conjugates.
  • In vitro studies to assess cellular uptake and cytotoxicity.
  • Comparative analysis with non-steroidal platinum(II) analogues.

Main Results:

  • Androgenic platinum conjugates demonstrated improved cellular delivery efficiency compared to non-steroidal analogues.
  • Synergistic effects were observed between the platinum(II) center and the steroidal androgen ligand.
  • The conjugates exhibited significantly enhanced potency, transforming inactive components into highly effective platinum(II) complexes.

Conclusions:

  • Conjugating androgens to platinum(II) complexes offers a promising strategy for targeted cancer therapy.
  • These novel agents overcome limitations of traditional platinum drugs by leveraging AR overexpression.
  • The developed androgenic platinum conjugates represent a new class of potent and selective anticancer agents.

More Related Videos

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids07:14

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids

Published on: May 16, 2025

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...